Century Therapeutics, Inc.IPSCNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | -85.52% |
| Q3 2025 | -11.13% |
| Q2 2025 | -11.73% |
| Q1 2025 | 8.42% |
| Q4 2024 | -7.15% |
| Q3 2024 | 0.55% |
| Q2 2024 | -5.00% |
| Q1 2024 | 1.79% |
| Q4 2023 | -4.42% |
| Q3 2023 | 9.20% |
| Q2 2023 | 22.24% |
| Q1 2023 | 38.55% |
| Q4 2022 | -39.74% |
| Q3 2022 | -2.29% |
| Q2 2022 | 13.09% |
| Q1 2022 | 70.04% |
| Q4 2021 | -18.06% |
| Q3 2021 | 66.13% |
| Q2 2021 | 81.21% |
| Q1 2021 | -38.21% |
| Q4 2020 | 21.43% |
| Q3 2020 | 14.35% |
| Q2 2020 | -1.07% |
| Q1 2020 | 0.00% |